Guardant Health Inc

Company Profile

Guardant Health Inc had its IPO on 2018-10-04 under the ticker symbol GH.

The company operates in the Healthcare sector and Diagnostics & Research industry. Guardant Health Inc has a staff strength of 1,793 employees.

Stock update

Shares of Guardant Health Inc opened at $33.03 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $32.24 - $33.46, and closed at $32.5.

This is a -2.61% slip from the previous day's closing price.

A total volume of 1,669,749 shares were traded at the close of the day’s session.

In the last one week, shares of Guardant Health Inc have slipped by -7.17%.

Guardant Health Inc's Key Ratios

Guardant Health Inc has a market cap of $4.12 billion, indicating a price to book ratio of 25.9492 and a price to sales ratio of 9.8119.

In the last 12-months Guardant Health Inc’s revenue was $510.16 million with a gross profit of $293.21 million and an EBITDA of $-508432992. The EBITDA ratio measures Guardant Health Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Guardant Health Inc’s operating margin was -107.69% while its return on assets stood at -18.59% with a return of equity of -166.14%.

In Q2, Guardant Health Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 25.7%.

Guardant Health Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-4.29 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Guardant Health Inc’s profitability.

Guardant Health Inc stock is trading at a EV to sales ratio of 11.0092 and a EV to EBITDA ratio of -8.5917. Its price to sales ratio in the trailing 12-months stood at 9.8119.

Guardant Health Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.84 billion

Total Liabilities

$200.93 million

Operating Cash Flow

$-241127000.00

Capital Expenditure

$6.51 million

Dividend Payout Ratio

0%

Guardant Health Inc ended 2024 with $1.84 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.84 billion while shareholder equity stood at $292.73 million.

Guardant Health Inc ended 2024 with $0 in deferred long-term liabilities, $200.93 million in other current liabilities, 1000.00 in common stock, $-1868717000.00 in retained earnings and $3.29 million in goodwill. Its cash balance stood at $271.07 million and cash and short-term investments were $1.22 billion. The company’s total short-term debt was $24,707,000 while long-term debt stood at $1.14 billion.

Guardant Health Inc’s total current assets stands at $1.40 billion while long-term investments were $0 and short-term investments were $953.78 million. Its net receivables were $86.47 million compared to accounts payable of $79.78 million and inventory worth $60.53 million.

In 2024, Guardant Health Inc's operating cash flow was $-241127000.00 while its capital expenditure stood at $6.51 million.

Comparatively, Guardant Health Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$32.5

52-Week High

$62.75

52-Week Low

$20.67

Analyst Target Price

$54.18

Guardant Health Inc stock is currently trading at $32.5 per share. It touched a 52-week high of $62.75 and a 52-week low of $62.75. Analysts tracking the stock have a 12-month average target price of $54.18.

Its 50-day moving average was $36.96 and 200-day moving average was $32.31 The short ratio stood at 5.22 indicating a short percent outstanding of 0%.

Around 429.9% of the company’s stock are held by insiders while 8031.4% are held by institutions.